Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
about
Interventions for deliberately altering blood pressure in acute strokeBlood Pressure in Acute Ischemic StrokeEffects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysisElevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers.Emergency department adherence to American Heart Association guidelines for blood pressure management in acute ischemic stroke.Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality: A Meta-Analysis of Current Literature.Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS networkTemporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patientsPPAR agonists as therapeutics for CNS trauma and neurological diseasesCurrent therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Renin-angiotensin system blocking drugs.Control of blood pressure in hypertensive neurological emergencies.Timing of blood pressure lowering in acute ischemic stroke.Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).Effect of Telmisartan on Cerebral and Systemic Haemodynamics in Patients with Recent Ischaemic Stroke: A Randomised Controlled TrialEfficacy of Antihypertensive Therapy in the Acute Stage of Cerebral Infarction - A Prospective, Randomized Control Trial
P2860
Q24193073-661CBED0-A6CC-485E-B82C-A423B2B615D5Q26772872-A3EC1BD8-A55A-44E8-AD19-258F756D1A06Q33650324-DBB0D498-0D19-45E8-9D85-D6FDC8FC8478Q34595301-F64FBE18-6683-4C92-8985-B4DC1B8ADF42Q35693384-D44890F6-1B92-49F5-96E6-3B6CBC20C17AQ36194203-1D758A25-DFBC-4025-8720-D3BDE5973C01Q36342027-7FF64CE2-735C-4F93-8B9D-8166478132CDQ36817489-19492AEC-A578-4C19-98B8-6AC54B65B4A4Q37400355-971FBFEC-2B47-423F-9AB3-B97E45601C2DQ37971308-953B9BF3-7C23-4257-A4AE-7508D1605444Q38137851-4F2221B9-402D-4487-AE5E-E211AB81BE93Q38207521-95AD9B99-D279-475B-A602-E5E9F232F056Q38515119-0A9F822C-7CD4-486D-849F-FF919DDA266BQ42883562-B65D5149-E6E6-42AC-9305-86D01A749FB3Q58996423-065C793A-DF47-4BFA-A5E3-70EAA15FC987Q59131720-DB25976C-6774-430D-A97E-B7C4B1663783
P2860
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@en
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@nl
type
label
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@en
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@nl
prefLabel
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@en
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@nl
P2093
P50
P1433
P1476
Effect of telmisartan on funct ...... : a PRoFESS subgroup analysis.
@en
P2093
Conrado Estol
Daniel Cotton
Danilo Toni
PRoFESS Study Group
Reneé H Martin
Robin Roberts
Yuko Palesch
P304
P356
10.1161/STROKEAHA.109.555623
P407
P577
2009-09-24T00:00:00Z